The Inhalation Anesthesia Market is projected to
reach USD 1,224.27 Million by 2030 at 8.50% CAGR during the forecast period
2022-2030.
The global inhalation anesthesia market is mainly driven by the
increasing number of surgical procedures being conducted around the world and
was valued at USD 1.12 billion in 2018. The market is profiled in detail in the
report, which includes detailed historical profiles of the major factors
affecting the market’s growth trajectory. Major drivers and restraints
affecting the inhalation anesthesia market are profiled in the report. Key
players operating in the inhalation anesthesia market are also profiled in the
report to give readers a clear idea of the competitive dynamics in the market.
Inhalation anesthesia is a process of
delivering anesthesia via inhalation rather than injection. Inhalation anesthesia
is widely used for inducing as well as maintaining sedation in patients
undergoing surgical procedures. Maintaining sedation is the primary application
of inhalation anesthesia rather than inducing it, as the dosage and effect of
inhalation anesthesia can be judged more accurately than injected anesthesia.
The increasing demand for minimally invasive or noninvasive procedures in the
healthcare sector is likely to be a major driver for the inhalation anesthesia
market over the forecast period. Rather than being injected into the body,
inhalation anesthesia materials are administered by inhalation, allowing
painless administration of anesthesia. This has helped the inhalation general
anesthesia market achieve steady growth in recent years and is likely to remain
a major driver for the market in the coming years.
The increasing demand for surgical
procedures is likely to be a major driver for the inhalation anesthesia market
over the forecast period. The increasing geriatric population around the world is
likely to be a key factor driving up the demand for surgeries, as the geriatric
population is more likely to require surgeries than younger demographics. The
increasing prevalence of cancer, cardiovascular conditions, and neurological
conditions is also likely to drive up the demand for surgical procedures in the
coming years, thus acting as a significant growth driver for the inhalation
anesthesia market.
Competitive
Analysis:
The inhalation anesthesia market players are AbbVie Inc., Fresenius Kabi
AG, Jiangsu Hengrui Medicine Co. Ltd., Piramal Enterprises Ltd., Lunan
Pharmaceutical Group Co. Ltd., Hikima Pharmaceuticals plc, Halocarbon Products
Corporation, and Baxter International Inc. Leading players in the global
inhalation anesthesia market are likely to focus on the development of more
effective anesthesia products in the coming years. Eliminating the risk of side
effects and maximizing the potency of the anesthesia agent is likely to be a
key objective for inhalation anesthesia market players over the forecast
period.
Segmentation:
The global inhalation anesthesia market is
segmented on the basis of product type, application, and region.
By product, the global inhalation
anesthesia market is segmented into sevoflurane, isoflurane, and desflurane.
By application, the global inhalation
anesthesia market is segmented into induction and maintenance.
Regional Analysis:
The report covers the Americas, Europe,
Asia Pacific, and MEA (Middle East and Africa) regional markets to provide a
comprehensive breakdown of the inhalation anesthesia market’s presence in each
region. The Americas are likely to remain the dominant force in the global
inhalation anesthesia market over the forecast period, with North America
dominating the global charts for production as well as usage of inhalation
anesthetics. The Americas region held a share of close to 50% in the global
inhalation anesthesia market in 2018 and is likely to remain a major regional
market for inhalation anesthesia in the coming years. Widespread presence of
advanced healthcare infrastructure and awareness about inhalation anesthetics
are the major drivers for the inhalation anesthesia market in North America.
Europe accounts for the second largest
share in the global inhalation anesthesia market, holding around 30% of the
global market. Strong development in healthcare research is likely to be a
major driver for the inhalation anesthesia market in the region over the
forecast period.
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment